SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001368993-17-000020
Filing Date
2017-03-01
Accepted
2017-03-01 06:00:22
Documents
5
Period of Report
2017-02-28
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K wgbs-form8xkannouncingmerg.htm 8-K 43431
2 EXHIBIT 3.1 ex31-wgbsarticles.htm EX-3.1 36844
3 EXHIBIT 3.2 ex32-wgbsbylaws.htm EX-3.2 55347
4 ex32bar.jpg GRAPHIC 4597
5 ex32pic1.jpg GRAPHIC 10659
  Complete submission text file 0001368993-17-000020.txt   158628
Mailing Address 34700 CAMPUS DRIVE FREMONT CA 94555
Business Address 34700 CAMPUS DRIVE FREMONT CA 94555 (510) 651-4450
WaferGen Bio-systems, Inc. (Filer) CIK: 0001368993 (see all company filings)

IRS No.: 900416683 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36601 | Film No.: 17651235
SIC: 3826 Laboratory Analytical Instruments